SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 2013 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?


To: hdl who wrote (305)9/25/2013 7:50:08 PM
From: BulbaMan  Read Replies (1) | Respond to of 410
 
The hedge funds probably saw something they liked in IDRA when the secondary was pitched and couldn’t get all the shares they wanted at $1.55. Also, there’s been notable insider buying and a positive SA article today. Here’s the SA link:
seekingalpha.com
The fact that IDRA traded above the secondary price is, according to the Biomaven rule, a very good omen.
Peace & good health,
Bulba